Cutaneous Gamma-Delta T-Cell Lymphoma Successfully Treated With Brentuximab Vedotin

JAMA Dermatol. 2016 Dec 1;152(12):1388-1390. doi: 10.1001/jamadermatol.2016.3117.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Biopsy
  • Brentuximab Vedotin
  • Humans
  • Immunoconjugates / therapeutic use*
  • Lymphoma, T-Cell, Cutaneous / diagnosis
  • Lymphoma, T-Cell, Cutaneous / drug therapy*
  • Male
  • Skin / pathology*
  • Treatment Outcome

Substances

  • Immunoconjugates
  • Brentuximab Vedotin